Log in or Sign up for Free to view tailored content for your specialty!
Biologics News
Kuros completes financing round, adds new board members
Kuros Biosurgery AG recently announced it has completed a CHF 15M financing round.
SeaSpine launches new interbody device
SeaSpine Holdings Corporation recently announced the launch of its Ventura NanoMetalene transforaminal intervertebral body fusion device, according to a company release.
Log in or Sign up for Free to view tailored content for your specialty!
FDA issues draft guidance on nonproprietary naming of biologics, biosimilars
The FDA today announced the availability of a draft guidance describing its proposal on the nonproprietary naming of biological products.
PRP likely not superior to viscosupplementation for knee OA
Researchers of this randomized controlled trial found that compared with hyaluronic acid, platelet-rich plasma did not provide superior clinical improvement and hold that it should not be preferred to viscosupplementation for the treatment of patients with knee cartilage degeneration and osteoarthritis.
Xtant Medical announces FDA approval of DBM putty
Xtant Medical Holdings Inc. recently announced its subsidiary, Bacterin International Inc., has received FDA 510(k) clearance of OsteoSelect PLUS Demineralized Bone Matrix Putty.
ISTO awarded NIH grant for study of biosynthetic scaffold
ISTO Technologies recently announced it has received a grant from the NIH to fund research for the application of the company’s new biosynthetic scaffold.
Ortho RTi acquires technology to aid in joint tissue regeneration
Ortho RTi has announced an agreement to acquire a platform technology to repair and regenerate damaged joints. The agreement, which is between Ortho RTi, Gestion Univalor and Polytechnique Montréal, will see Univalor transfer multiple patent applications and related information to Ortho RTi.
Baker awarded grant for stem cell-based PTOA research
Beaumont Orthopedics recently announced Kevin Baker, PhD, Beaumont – Royal Oak orthopedic research laboratories director, has been awarded a $260,000 Congressionally Directed Medical Research Program grant to study post-traumatic osteoarthritis.
Low retear rate found with absorbable biologic scaffold-reinforced rotator cuff repair
ORLANDO, Fla. — Among patients who underwent arthroscopic rotator cuff repair reinforced with an absorbable biologic scaffold for treatment of full-thickness tears, researchers observed a low retear rate, along with improved function and clinical outcome scores.
Gender should be considered in diagnosis and treatment of musculoskeletal diseases
When caring for orthopedic patients, physicians must consider the role of hormones, differential anatomy, joint stability and bone quality, as well as differences in recovery after injury and surgery among men and women, according to researchers.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read